Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma

par Hongjin Wu, Weiwei Tian, Xiang Tai, Xuanpeng Li, Ziwei Li, Jing Shui, Juehua Yu, Zhihua Wang, Xiaosong Zhu
Publié 2021

Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regu...

par Paula Marie Schmidtlein, Clara Volz, Alexander Hackel, Isabel Thürling, Darko Castven, Rüdiger Braun, Ulrich Friedrich Wellner, Björn Konukiewitz, Gabriela Riemekasten, Hendrik Lehnert, Jens-Uwe Marquardt, Hendrik Ungefroren
Publié 2021

Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance

par Shin-Heng Chiou, Madeleine Dorsch, Eva Kusch, Santiago Naranjo, Margaret M. Kozak, Albert C. Koong, Monte M. Winslow, Barbara M. Grüner
Publié 2018

Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology

par Alin Mihai Vasilescu, Delia Florina Andriesi Rusu, Costel Bradea, Nutu Vlad, Corina Lupascu-Ursulescu, Irene Alexandra Cianga Spiridon, Ana Maria Trofin, Eugen Tarcoveanu, Cristian Dumitru Lupascu
Publié 2021

Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study

par Sang Myung Woo, Min Kyeong Kim, Boram Park, Eun-Hae Cho, Tae-Rim Lee, Chang-Seok Ki, Kyong-Ah Yoon, Yun-Hee Kim, Wonyoung Choi, Do Yei Kim, Jin-Hyeok Hwang, Jae Hee Cho, Sung-Sik Han, Woo Jin Lee, Sang-Jae Park, Sun-Young Kong
Publié 2021

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance

par Kostas Palamaris, Evangelos Felekouras, Stratigoula Sakellariou
Publié 2021

The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma

par Ricki T. Krog, Noel F. C. C. de Miranda, Alexander L. Vahrmeijer, Nigel G. Kooreman
Publié 2021

Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma

par Chiaki Uchida, Hiroki Mizukami, Yutaro Hara, Takeshi Saito, Satoko Umetsu, Akiko Igawa, Sho Osonoi, Kazuhiro Kudoh, Yasuhiko Yamamoto, Hiroshi Yamamoto, Soroku Yagihashi, Kenichi Hakamada
Publié 2021

Context Matters—Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer

par Sushmitha Sankarasubramanian, Sushmitha Sankarasubramanian, Ulrike Pfohl, Ulrike Pfohl, Ulrike Pfohl, Christian R. A. Regenbrecht, Christian R. A. Regenbrecht, Christian R. A. Regenbrecht, Christoph Reinhard, Christoph Reinhard, Lena Wedeken, Lena Wedeken
Publié 2021

Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer

par Ruthger van Roey, Thomas Brabletz, Marc P. Stemmler, Isabell Armstark
Publié 2021

TPH1 and 5-HT₇ Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma

par Prakash Chaudhary, Diwakar Guragain, Jae-Hoon Chang, Jung-Ae Kim
Publié 2021

Long Non-Coding RNAs in Epithelial-Mesenchymal Transition of Pancreatic Cancer

par Kenji Takahashi, Kenzui Taniue, Kenzui Taniue, Yusuke Ono, Mikihiro Fujiya, Yusuke Mizukami, Yusuke Mizukami, Toshikatsu Okumura
Publié 2021